PAX6 and central nervous system cancer: Specifically, PAX6 expression in grade 3–4 gliomas was significantly lower than in normal tissues, while no statistically significant difference was observed between grade 1–2 tumors and normal samples (Figure 1A,B, * p < 0.05).